XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Balances at beginning of period at Dec. 31, 2020 $ 15,815 $ 10 $ 308,065 $ (291,163) $ (1,097)
Balances at beginning of period (in shares) at Dec. 31, 2020   9,743,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock through equity distribution agreement, net of offering costs 41,679 $ 5 41,674    
Issuance of common stock through equity distribution agreement, net of offering costs (in shares)   5,502,000      
Issuance of common stock from vesting of restricted stock units (in shares)   233,000      
Tax withholding related to vesting of restricted stock units (269)   (269)    
Issuance of common stock under employee stock purchase plan 16   16    
Issuance of common stock under employee stock purchase plan (in shares)   13,000      
Stock-based compensation expense 1,336   1,336    
Net loss (7,843)     (7,843)  
Foreign currency translation adjustments (10)       (10)
Balances at end of period at Sep. 30, 2021 50,724 $ 15 350,822 (299,006) (1,107)
Balances at end of period (in shares) at Sep. 30, 2021   15,491,000      
Balances at beginning of period at Dec. 31, 2020 15,815 $ 10 308,065 (291,163) (1,097)
Balances at beginning of period (in shares) at Dec. 31, 2020   9,743,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (12,944)        
Balances at end of period at Dec. 31, 2021 46,258 [1] $ 15 351,394 (304,107) (1,044)
Balances at end of period (in shares) at Dec. 31, 2021   15,532,000      
Balances at beginning of period at Jun. 30, 2021 14,677 $ 11 311,675 (295,876) (1,133)
Balances at beginning of period (in shares) at Jun. 30, 2021   11,147,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock through equity distribution agreement, net of offering costs 38,654 $ 4 38,650    
Issuance of common stock through equity distribution agreement, net of offering costs (in shares)   4,316,000      
Issuance of common stock from vesting of restricted stock units (in shares)   28,000      
Tax withholding related to vesting of restricted stock units (158)   (158)    
Stock-based compensation expense 655   655    
Net loss (3,130)     (3,130)  
Foreign currency translation adjustments 26       26
Balances at end of period at Sep. 30, 2021 50,724 $ 15 350,822 (299,006) (1,107)
Balances at end of period (in shares) at Sep. 30, 2021   15,491,000      
Balances at beginning of period at Dec. 31, 2021 46,258 [1] $ 15 351,394 (304,107) (1,044)
Balances at beginning of period (in shares) at Dec. 31, 2021   15,532,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from vesting of restricted stock units (in shares)   557,000      
Tax withholding related to vesting of restricted stock units (404)   (404)    
Issuance of common stock under employee stock purchase plan 22 $ 1 21    
Issuance of common stock under employee stock purchase plan (in shares)   13,000      
Stock-based compensation expense 2,691   2,691    
Net loss (13,109)     (13,109)  
Foreign currency translation adjustments 83       83
Balances at end of period at Sep. 30, 2022 35,541 $ 16 353,702 (317,216) (961)
Balances at end of period (in shares) at Sep. 30, 2022   16,102,000      
Balances at beginning of period at Jun. 30, 2022 40,551 $ 16 353,018 (311,480) (1,003)
Balances at beginning of period (in shares) at Jun. 30, 2022   15,887,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from vesting of restricted stock units (in shares)   215,000      
Tax withholding related to vesting of restricted stock units (300)   (300)    
Stock-based compensation expense 984   984    
Net loss (5,736)     (5,736)  
Foreign currency translation adjustments 42       42
Balances at end of period at Sep. 30, 2022 $ 35,541 $ 16 $ 353,702 $ (317,216) $ (961)
Balances at end of period (in shares) at Sep. 30, 2022   16,102,000      
[1] Derived from the Company’s audited consolidated financial statements as of December 31, 2021.